Antidepressant-induced Tardive Syndrome: a Retrospective Epidemiological Study

Abstract

Introduction:

The impact of using antidepressant on the occurrence of tardive syndrome is rarely studied. Here we aimed to investigate the prevalence of various types of antidepressant-induced tardive syndrome.

Methods:

This study was conducted by means of a retrospective survey. Subjects receiving antidepressant(s) for over 6 months, but no other agents that may cause involuntary movements, were consecutively recruited. Tardive syndrome was evaluated in every included subject. Possible confounding medical conditions were carefully ruled out.

Results:

Of the 158 included subjects, 22 (14.0%) were found to have at least one tardive syndrome. The prevalence of subtypes of tardive syndromes was: tardive dystonia: 10.8%, tardive dykinesia: 3.2%, tardive tremor: 1.3%, tardive parkinsonism: 1.3%, tardive tics: 1.3%, tardive sensory syndrome: 1.3%, and tardive myoclonus: 0.6%. Using serotonin-norepinephrine reuptake inhibitors and previous marital status significantly increase the risk of tardive syndrome.

Discussion:

This study showed that antide­pressants may induce various types of tardive syndrome, of which tardive dystonia is the predominant form. Clinicians should be cautious of this infrequent but distressing adverse effect when using antidepressants.

Key words

antidepressant - tardive syndrome - tardive dystonia

• References

• 1 Bressan RA, Erlandsson K, Jones HM et al. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [¹²³I]epidepride SPET study of amisulpride-treated patients. Am J Psychiatry 2003; 160: 1413-1420
• 2 Fahn S, Jankovic J. The tardive syndromes phenomenology, concepts on pathophysiology and treatment, and other neuroleptic-induced syndromes. In: Principles and Practice of Movement Disorders. Churchill Livingstone press; Philadelphia: 2007. 479-518
• 3 Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol 1995; 18: 197-214
• 4 Fernandez HH, Friedman JH. Classification and treatment of tardive syndromes. Neurologist 2003; 9: 16-27
• 5 Browne S, Roe M, Lane A et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 1996; 94: 118-124
• 6 Gill HS, DeVane CL, Risch SC. Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses. J Clin Psychopharmacol 1997; 17: 377-389
• 7 Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996; 57: 449-454
• 8 Dubovsky SL, Thomas M. Tardive dyskinesia associated with fluoxetine. Psychiatr Serv 1996; 47: 991-993
• 9 Botsaris SD, Sypek JM. Paroxetine and tardive dyskinesia. J Clin Psychopharmacol 1996; 16: 258-259
• 10 Birthi P, Walters C, Karandikar N. A rare case of tardive dyskinesia and akathisia induced by citalopram. Pm R 2010; 2: 973-975
• 11 Deuschle M, Mase E, Zink M. Dyskinesia during treatment with duloxetine. Pharmacopsychiatry 2006; 39: 237-238
• 12 Yassa R, Camille Y, Belzile L. Tardive dyskinesia in the course of antidepressant therapy: a prevalence study and review of the literature. J Clin Psychopharmacol 1987; 7: 243-246
• 13 Skidmore F, Reich SG. Tardive dystonia. Curr Treat Options Neurol 2005; 7: 231-236
• 14 van Harten PN, Kahn RS. Tardive dystonia. Schizophr Bull 1999; 25: 741-748
• 15 Chen PY, Lin PY, Tien SC et al. Duloxetine-related tardive dystonia and tardive dyskinesia: a case report. Gen Hosp Psychiatry 2010; 32: 646 e649-646 e611
• 16 Lin CC, Lin PY, Lee Y et al. Tardive dystonia and tardive sensory syndrome related to trazodone: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1609-1610
• 17 Lee Y, Yeh WC, Chong MY et al. Venlafaxine and tardive blepharospasm: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1139-1140
• 18 Fountoulakis KN, Samara M, Siapera M et al. Tardive Tourette-like syndrome: a systematic review. Int Clin Psychopharmacol 2011; 26: 237-242
• 19 Little JT, Jankovic J. Tardive myoclonus. Mov Disord 1987; 2: 307-311
• 20 Ford B, Greene P, Fahn S. Oral and genital tardive pain syndromes. Neurology 1994; 44: 2115-2119
• 21 Chen CK, Wu JH. Improvement of risperidone-related tardive parkinsonism with a switch to aripiprazole. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 1279-1280
• 22 Stacy M, Jankovic J. Tardive tremor. Mov Disord 1992; 7: 53-57
• 23 Tarsy D, Indorf G. Tardive tremor due to metoclopramide. Mov Disord 2002; 17: 620-621
• 24 Fennig S, Fennig SN, Pato M et al. Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder. Br J Psychiatry 1994; 164: 839-841
• 25 Buscombe C, Alusi SH, Kahn DA. A biopsychosocial approach to improving quality of life in tardive dystonia. J Psychiatr Pract 2010; 16: 350-357
• 26 Tarsy D, Baldessarini RJ. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?. Mov Disord 2006; 21: 589-598
• 27 American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revision. (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000
• 28 Chouinard G, Margolese HC. Manual for the extrapyramidal symptom rating scale (ESRS). Schizophr Res 2005; 76: 247-265
• 29 Correll CU, Schenk EM. Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry 2008; 21: 151-156
• 30 Aityanjee Aderibigbe YA, Jampala VC. et al. The current status of tardive dystonia. Biol Psychiatry 1999; 45: 715-730
• 31 Remington GJ. The Pisa syndrome: possible role for serotonin and noradrenaline. J Clin Psychopharmacol 1988; 8: 228-229
• 32 Kulkarni SK, Naidu PS. Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives. Drugs Today (Barc) 2003; 39: 19-49
• 33 Madhusoodanan S, Alexeenko L, Sanders R et al. Extrapyramidal symptoms associated with antidepressants – a review of the literature and an analysis of spontaneous reports. Ann Clin Psychiatry 2010; 22: 148-156
• 34 Schillevoort I, van Puijenbroek EP, de Boer A et al. Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports. Int Clin Psychopharmacol 2002; 17: 75-79
• 35 Libov I, Miodownik C, Bersudsky Y et al. Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study. J Clin Psychiatry 2007; 68: 1031-1037
• 36 Lerner V, Miodownik C, Kaptsan A et al. Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study. J Clin Psychiatry 2007; 68: 1648-1654